News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-08 4:1:29 am Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference GlobeNewsWire
2024-03-01 6:40:11 am Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year? Zacks
2024-02-28 9:0:10 am Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy? Zacks
2024-02-22 1:5:0 pm Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates GlobeNewswire
2024-02-15 11:56:39 am 2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More) TipRanks
2024-02-08 1:2:0 pm Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) GlobeNewswire
2024-01-22 2:55:51 am With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors Simply Wall St.
2024-01-08 4:0:0 am Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update GlobeNewswire
2024-01-03 4:0:0 am Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information